THERAPEUTIC CONTROVERSIES - CLINICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

被引：22

作者：

GELLER, J ^{[1
]}

KIRSCHENBAUM, A ^{[1
]}

LEPOR, H ^{[1
]}

LEVINE, AC ^{[1
]}

机构：

[1] MERCY HOSP & MED CTR, SAN DIEGO, CA USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1995年 / 80卷 / 03期

关键词：

D O I：

10.1210/jc.80.3.745

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：745 / 747

页数：3

共 50 条

[21] Laser treatment of benign prostatic hyperplasia
Kuntz, Rainer M.
WORLD JOURNAL OF UROLOGY, 2007, 25 (03) : 241 - 247
[22] Laser treatment of benign prostatic hyperplasia
Mallet, Richard
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (07): : 1487 - 1498
[23] PERMIXON TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
GORILOVSKY, LM
TERAPEVTICHESKII ARKHIV, 1995, 67 (08) : 62 - 64
[24] Silodosin in the treatment of benign prostatic hyperplasia
Rossi, Maxime
Roumeguere, Thierry
DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 291 - 297
[25] PHARMACOLOGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
PASCUAL, J
WOODHOUSE, K
BRITISH JOURNAL OF CLINICAL PRACTICE, 1994, 48 (03): : 137 - 138
[26] CONSERVATIVE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
SCHOENENBERGER, A
HAURI, D
THERAPEUTISCHE UMSCHAU, 1982, 39 (04) : 260 - 267
[27] Laser treatment of benign prostatic hyperplasia
Rainer M. Kuntz
World Journal of Urology, 2007, 25 : 241 - 247
[28] Pharmacological treatment of benign prostatic hyperplasia
Oelke, M.
Martinelli, E.
UROLOGE, 2016, 55 (01): : 81 - 94
[29] PHARMACOLOGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
WHITEFIELD, H
HENDRY, B
BRITISH JOURNAL OF UROLOGY, 1995, 76 : R5 - R5
[30] Guidelines for the Treatment of Benign Prostatic Hyperplasia
Wu, Yunuo
Davidian, Michael H.
DeSimone, Edward M., II
US PHARMACIST, 2016, 41 (08) : 36 - 40